High-mobility group box 1 emerges as a therapeutic target for asthma

Area of Science:

• Molecular Biology
• Immunology
• Cellular Biology

Background:

• High-mobility group box 1 (HMGB1) is a nuclear protein involved in DNA processes and cellular stress.
• Extracellular HMGB1 functions as a potent inflammatory mediator, triggering immune responses.
• HMGB1 signaling pathways, including HMGB1/RAGE and HMGB1/NF-κB, are critical in inflammation.

Purpose of the Study:

• To elucidate the role of HMGB1 in inflammatory processes.
• To investigate the involvement of HMGB1 in asthma pathogenesis.
• To identify HMGB1 as a potential therapeutic target for asthma.

Main Methods:

• Review of intracellular and extracellular functions of HMGB1.
• Analysis of HMGB1's role in various signaling pathways (e.g., HMGB1/RAGE, HMGB1/NF-κB, HMGB1/JAK/STAT).
• Examination of HMGB1's involvement in asthma-related signaling pathways (e.g., HMGB1/TLR4/NF-κB, HMGB1/RAGE, HMGB1/TGF-β).

Main Results:

• HMGB1 regulates intracellular functions including DNA transcription, replication, and repair.
• Extracellular HMGB1 acts as a pro-inflammatory cytokine, initiating inflammatory and immune responses.
• HMGB1 mediates key signaling pathways implicated in asthma development.

Conclusions:

• HMGB1 plays a significant role in mediating inflammatory and immune responses.
• HMGB1 is intricately involved in the pathogenesis of asthma.
• Targeting HMGB1 offers a promising therapeutic strategy for asthma treatment.